BCL2 and prostate carcinoma: AKT activated by PI3K leads to the activation of NFkB, which then translocates to the nucleus and transcribes BCL2. In this study, we show that CYP1A1 knockdown can cause reduction of AKT phosphorylation in prostate cancer cells and this effect was also shown in breast cancer cells [8].